Prior studies indicated that higher levels of testosterone and sex hormone-binding globulin (SHBG) in middle-aged males are associated with a reduced risk of metabolic syndrome [15] and women with type 2 diabetes (T2D) had lower SHBG levels [16]. This evidence concerns the gene SHBG and metabolic syndrome.